“Lebrikizumab Treatment Improves Lichenification and Other Clinical Signs of Atopic Dermatitis in Adults and Adolescents with Moderate-to-Severe AD and Skin of Color”, J of Skin, vol. 9, no. 6, p. s625, Nov. 2025, doi: 10.25251/0262jz84.